Last 12 months
Inside the activity.
1 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 1 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2024 Filed Feb 16, 2024 23:03 UTC |
Lettmann JasonDirector · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004210 · form4-02162024_110246.xml · nonDerivative · entry 1 Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,220 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 21:03 UTC |
Wong ShellySVP, Finance and CAO
|
SaleCommon Stock | 2,717 | $13.60 | $36,956.63 |
DisclosureSEC source: 0001209191-24-000985 · doc4.xml · nonDerivative · entry 1 Pinto Shelly · CIK 0001857740 · SVP, Finance and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,591 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.59 to $13.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 16:25 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
SaleCommon Stock | 3,128 | $15.04 | $47,045.12 |
DisclosureSEC source: 0001209191-24-000374 · doc4.xml · nonDerivative · entry 1 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312,349 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 16:17 UTC |
Pons JaumeDirector · President & CSO
|
SaleCommon Stock | 7,179 | $15.04 | $107,972.16 |
DisclosureSEC source: 0001209191-24-000359 · doc4.xml · nonDerivative · entry 1 Pons Jaume · CIK 0001816977 · Director · President & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 618,359 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:28 UTC |
Wong ShellySVP, Finance and CAO
|
SaleCommon Stock | 1,631 | $15.04 | $24,530.24 |
DisclosureSEC source: 0001209191-24-000379 · doc4.xml · nonDerivative · entry 1 Pinto Shelly · CIK 0001857740 · SVP, Finance and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,308 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. F2 · balance_after: Includes 1,226 shares acquired under the Issuer's employee stock purchase plan on December 29, 2023. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:20 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 1,893 | $15.04 | $28,470.72 |
DisclosureSEC source: 0001209191-24-000366 · doc4.xml · nonDerivative · entry 1 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,348 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. F2 · balance_after: Includes 503 shares acquired under the Issuer's employee stock purchase plan on December 29, 2023. Read SEC document |
| September 08, 2023 Filed Sep 12, 2023 20:24 UTC |
Lettmann JasonDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 1,200,000 | $0.00 Strike: $4.92 | $0.00 |
DisclosureSEC source: 0001209191-23-049102 · doc4.xml · derivative · entry 1 Lettmann Jason · CIK 0001688269 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,200,000 Underlying: Common Stock · 1,200,000 shares Expires 2033-09-07 F1 · derivative.exercise_date: One-fourth of the shares subject to the option vest on September 5, 2024 and 1/48th of the shares vest monthly thereafter. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 16:11 UTC |
Pons JaumeDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 282,000 | $0.00 Strike: $5.86 | $0.00 |
DisclosureSEC source: 0001209191-23-043514 · doc4.xml · derivative · entry 2 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,000 Underlying: Common Stock · 282,000 shares Expires 2033-07-24 F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 16:11 UTC |
Pons JaumeDirector · President & CEO
|
GrantCommon Stock | 89,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-043514 · doc4.xml · nonDerivative · entry 1 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,538 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 16:27 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
GrantCommon Stock · Derivative | 107,000 | $0.00 Strike: $5.86 | $0.00 |
DisclosureSEC source: 0001209191-23-043531 · doc4.xml · derivative · entry 2 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,000 Underlying: Common Stock · 107,000 shares Expires 2033-07-24 F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 16:27 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
GrantCommon Stock | 34,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-043531 · doc4.xml · nonDerivative · entry 1 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,477 F1 · price: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:19 UTC |
Wong ShellySVP, Finance and CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 36,000 | $0.00 Strike: $5.86 | $0.00 |
DisclosureSEC source: 0001209191-23-043523 · doc4.xml · derivative · entry 2 Pinto Shelly · CIK 0001857740 · SVP, Finance and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2033-07-24 F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:19 UTC |
Wong ShellySVP, Finance and CAO
|
GrantCommon Stock | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-043523 · doc4.xml · nonDerivative · entry 1 Pinto Shelly · CIK 0001857740 · SVP, Finance and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,713 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:15 UTC |
GARCIA PETER SChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 101,000 | $0.00 Strike: $5.86 | $0.00 |
DisclosureSEC source: 0001209191-23-043519 · doc4.xml · derivative · entry 2 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,000 Underlying: Common Stock · 101,000 shares Expires 2033-07-24 F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:15 UTC |
GARCIA PETER SChief Financial Officer
|
GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-043519 · doc4.xml · nonDerivative · entry 1 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,738 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023. Read SEC document |
| July 06, 2023 Filed Jul 7, 2023 20:09 UTC |
Wong ShellyVP, Finance and CAO
|
SaleCommon Stock | 7,345 | $6.52 | $47,889.40 |
DisclosureSEC source: 0001209191-23-041790 · doc4.xml · nonDerivative · entry 1 Pinto Shelly · CIK 0001857740 · VP, Finance and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,713 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 17:09 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
SaleCommon Stock | 1,605 | $7.34 | $11,780.70 |
DisclosureSEC source: 0001209191-23-041204 · doc4.xml · nonDerivative · entry 1 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,477 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 17:07 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 3,208 | $7.34 | $23,546.72 |
DisclosureSEC source: 0001209191-23-041197 · doc4.xml · nonDerivative · entry 1 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 536,538 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:05 UTC |
Wong ShellyVP, Finance and CAO
|
SaleCommon Stock | 466 | $7.34 | $3,420.44 |
DisclosureSEC source: 0001209191-23-041189 · doc4.xml · nonDerivative · entry 1 Pinto Shelly · CIK 0001857740 · VP, Finance and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,058 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. F2 · balance_after: Includes 1,427 shares acquired under the Issuer's employee stock purchase plan on June 30, 2023. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:00 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 887 | $7.34 | $6,510.58 |
DisclosureSEC source: 0001209191-23-041175 · doc4.xml · nonDerivative · entry 1 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,738 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. F2 · balance_after: Includes 1,902 shares acquired under the Issuer's employee stock purchase plan on June 30, 2023. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 16:27 UTC |
Canamasas ItziarDirector
|
GrantStock Option (right to buy) · Derivative | 20,200 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001209191-23-039063 · doc4.xml · derivative · entry 1 Canamasas Itziar · CIK 0001921346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,200 Underlying: Common Stock · 20,200 shares Expires 2033-06-19 F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments on the 20th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 20:51 UTC |
Nielsen JackDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 20,200 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001209191-23-039109 · doc4.xml · derivative · entry 1 Nielsen Jack · CIK 0001602402 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,200 Underlying: Common Stock · 20,200 shares Expires 2033-06-19 F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments on the 20th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 20:46 UTC |
Lettmann JasonDirector · 10% owner
|
GrantStock option (right to buy) · Derivative | 20,200 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001209191-23-039103 · doc4.xml · derivative · entry 1 Lettmann Jason · CIK 0001688269 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,200 Underlying: Common Stock · 20,200 shares Expires 2033-06-19 F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments on the 20th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 20:43 UTC |
Hemrajani RekhaDirector
|
GrantStock Option (right to buy) · Derivative | 20,200 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001209191-23-039096 · doc4.xml · derivative · entry 1 Hemrajani Rekha · CIK 0001771213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,200 Underlying: Common Stock · 20,200 shares Expires 2033-06-19 F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments on the 20th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 20:32 UTC |
GOODMAN COREY SDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 20,200 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001209191-23-039082 · doc4.xml · derivative · entry 1 GOODMAN COREY S · CIK 0001278411 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,200 Underlying: Common Stock · 20,200 shares Expires 2033-06-19 F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments on the 20th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 20:30 UTC |
Garland J. ScottDirector
|
GrantStock Option (right to buy) · Derivative | 10,100 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001209191-23-039072 · doc4.xml · derivative · entry 1 Garland J. Scott · CIK 0001533228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,100 Underlying: Common Stock · 10,100 shares Expires 2033-06-19 F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments on the 20th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 16:38 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,256 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001209191-23-036733 · doc4.xml · derivative · entry 6 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,084 Underlying: Common Stock · 6,256 shares Expires 2030-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on May 27, 2020. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 16:38 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,546 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001209191-23-036733 · doc4.xml · derivative · entry 5 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,629 Underlying: Common Stock · 2,546 shares Expires 2030-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 16:38 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,027 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001209191-23-036733 · doc4.xml · derivative · entry 4 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,027 shares Expires 2029-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 16:38 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock | 6,256 | $4.81 | $30,091.36 |
DisclosureSEC source: 0001209191-23-036733 · doc4.xml · nonDerivative · entry 3 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 16:38 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock | 2,546 | $4.08 | $10,387.68 |
DisclosureSEC source: 0001209191-23-036733 · doc4.xml · nonDerivative · entry 2 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 16:38 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock | 4,027 | $1.91 | $7,691.57 |
DisclosureSEC source: 0001209191-23-036733 · doc4.xml · nonDerivative · entry 1 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 20:29 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 3,232 | $11.07 | $35,778.56 |
DisclosureSEC source: 0001209191-23-000472 · doc4.xml · nonDerivative · entry 1 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,746 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.07 to $11.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 20:47 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
SaleCommon Stock | 1,617 | $11.07 | $17,900.84 |
DisclosureSEC source: 0001209191-23-000483 · doc4.xml · nonDerivative · entry 1 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,253 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.07 to $11.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 29, 2022 Filed Jan 4, 2023 01:52 UTC |
Wong ShellyVP, Finance and CAO
|
SaleCommon Stock | 482 | $11.07 | $5,335.69 |
DisclosureSEC source: 0001209191-23-000485 · doc4.xml · nonDerivative · entry 1 Pinto Shelly · CIK 0001857740 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,097 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.04 to $11.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects a reduction of 139 shares previously reported as acquired pursuant to the Issuer's employee stock purchase plan on June 30, 2022. Read SEC document |
| December 29, 2022 Filed Jan 4, 2023 01:34 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 893 | $11.07 | $9,885.60 |
DisclosureSEC source: 0001209191-23-000475 · doc4.xml · nonDerivative · entry 1 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,723 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.07 to $11.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects a reduction of 562 shares previously reported as acquired pursuant to the Issuer's employee stock purchase plan on June 30, 2022. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 17:08 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,339 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001209191-22-062178 · doc4.xml · derivative · entry 6 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,340 Underlying: Common Stock · 25,339 shares Expires 2030-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on May 27, 2020. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 17:08 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,731 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001209191-22-062178 · doc4.xml · derivative · entry 5 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,175 Underlying: Common Stock · 12,731 shares Expires 2030-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 17:08 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,404 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001209191-22-062178 · doc4.xml · derivative · entry 4 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,027 Underlying: Common Stock · 8,404 shares Expires 2029-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 17:08 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock | 25,339 | $4.81 | $121,880.59 |
DisclosureSEC source: 0001209191-22-062178 · doc4.xml · nonDerivative · entry 3 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 17:08 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock | 12,731 | $4.08 | $51,942.48 |
DisclosureSEC source: 0001209191-22-062178 · doc4.xml · nonDerivative · entry 2 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 17:08 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock | 8,404 | $1.91 | $16,051.64 |
DisclosureSEC source: 0001209191-22-062178 · doc4.xml · nonDerivative · entry 1 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2022 Filed Nov 29, 2022 21:32 UTC |
Garland J. ScottDirector
|
GrantStock Option (right to buy) · Derivative | 24,009 | $0.00 Strike: $10.07 | $0.00 |
DisclosureSEC source: 0001209191-22-058946 · doc4.xml · derivative · entry 1 Garland J. Scott · CIK 0001533228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,009 Underlying: Common Stock · 24,009 shares Expires 2032-11-28 F1 · derivative.exercise_date: Shares subject to the option vest in 36 equal monthly installments beginning on December 28, 2022. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 18:10 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 123,000 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0001209191-22-045067 · doc4.xml · derivative · entry 2 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,000 Underlying: Common Stock · 123,000 shares Expires 2032-08-04 F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 1, 2022. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 18:10 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
GrantCommon Stock | 37,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-045067 · doc4.xml · nonDerivative · entry 1 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,396 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2022. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 17:55 UTC |
Pons JaumeDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 244,000 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0001209191-22-045054 · doc4.xml · derivative · entry 2 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,000 Underlying: Common Stock · 244,000 shares Expires 2032-08-04 F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 1, 2022. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 17:55 UTC |
Pons JaumeDirector · President & CEO
|
GrantCommon Stock | 74,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-045054 · doc4.xml · nonDerivative · entry 1 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 542,978 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2022. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 22:07 UTC |
Wong ShellyVP, Finance and CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 36,000 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0001209191-22-045064 · doc4.xml · derivative · entry 2 Pinto Shelly · CIK 0001857740 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2032-08-04 F3 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 1, 2022. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 22:07 UTC |
Wong ShellyVP, Finance and CAO
|
GrantCommon Stock | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-045064 · doc4.xml · nonDerivative · entry 1 Pinto Shelly · CIK 0001857740 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,718 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2022. F2 · balance_after: Includes 1,272 shares acquired under the Issuer's employee stock purchase plan on June 30, 2022. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:57 UTC |
GARCIA PETER SChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 95,000 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0001209191-22-045056 · doc4.xml · derivative · entry 2 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2032-08-04 F3 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 1, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.